Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

FDA rejects cancer drug invented in China in blow to Beijing’s biotech sector

Summit’s Ivonescimab was seen as a test case for whether the country’s medicine could pass scrutiny in the US

FDA rejects cancer drug invented in China in blow to Beijing’s biotech sector

We haven't written up this one. Financial Times has the full story — the link below goes straight to it.

This story

This is one outlet's version. Read the fullest account.

Every outlet that reported this, and when →

Read the original at ft.com →

More in Health & Medicine

More from Sunday 15 November →